(Q42654718)

4 November 2017

Treatment of resistant glomerular diseases with adrenocorticotropic hormone gel: a prospective trial (English)

1 reference

4 November 2017

3

1 reference

4 November 2017

Rivka Ayalon

4

0 references

Pietro A Canetta

object named as

Pietro A Canetta

2

0 references

author name string

Andrew S Bomback

1

1 reference

PubMed ID

22722778

4 November 2017

Jai Radhakrishnan

5

1 reference

PubMed ID

22722778

4 November 2017

Gerald B Appel

6

1 reference

4 November 2017

19 June 2012

1 reference

American Journal of Nephrology

4 November 2017

1 reference

4 November 2017

36

1 reference

4 November 2017

1

1 reference

4 November 2017

58-67

1 reference

Adult minimal-change disease: clinical characteristics, treatment, and outcomes.

4 November 2017

1 reference

Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial

21 January 2018

1 reference

Immunosuppressive treatment for idiopathic membranous nephropathy: a systematic review

21 January 2018

1 reference

A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group.

21 January 2018

1 reference

Focal and segmental glomerulosclerosis: definition and relevance of a partial remission

21 January 2018

1 reference

ACTH-induced improvement in the nephrotic syndrome in patients with a variety of diagnoses.

21 January 2018

1 reference

Beneficial effects of ACTH on the serum lipoprotein profile and glomerular function in patients with membranous nephropathy.

21 January 2018

1 reference

Treatment of nephrotic syndrome with adrenocorticotropic hormone (ACTH) gel

21 January 2018

1 reference

Melanocortin 1 receptor agonists reduce proteinuria

21 January 2018

1 reference

A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy

21 January 2018

1 reference

M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy

21 January 2018

1 reference

Treatment of IgA nephropathy with ACE inhibitors: a randomized and controlled trial

21 January 2018

1 reference

Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.

21 January 2018

1 reference

Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial

21 January 2018

1 reference

Rituximab therapy for membranous nephropathy: a systematic review

21 January 2018

1 reference

Rituximab treatment of idiopathic membranous nephropathy

21 January 2018

1 reference

Mycophenolate mofetil monotherapy in membranous nephropathy: a 1-year randomized controlled trial.

21 January 2018

1 reference

Rituximab treatment of adult patients with steroid-resistant focal segmental glomerulosclerosis

21 January 2018

1 reference

Successful treatment of membranous glomerulonephritis with rituximab in calcineurin inhibitor-dependent patients

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000339287

1 reference

4 November 2017

1 reference

PubMed ID

22722778